GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Hisoar Pharmaceutical Co Ltd (SZSE:002099) » Definitions » Valuation Rank

Zhejiang Hisoar Pharmaceutical Co (SZSE:002099) Valuation Rank


View and export this data going back to 2006. Start your Free Trial

What is Zhejiang Hisoar Pharmaceutical Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Zhejiang Hisoar Pharmaceutical Co Valuation Rank Related Terms

Thank you for viewing the detailed overview of Zhejiang Hisoar Pharmaceutical Co's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Hisoar Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 507 Shifu Avenue, Taizhou International Business Plaza, Block A, 8F, Taizhou, Zhejiang, CHN, 318000
Zhejiang Hisoar Pharmaceutical Co Ltd is a China-based company engages in the production of specialty raw materials, preparations and fine chemicals, dyes and dye intermediates. Its products include Clindamycin hydrochloride, Clindamycin phosphate, Florfenicol, Atova, Thiamphenicol, and Riglinay.
Executives
Wang Yang Chao Director
Yang Si Wei Directors, executives
Xu Guo Rui Executives
Xu Hua Qing Secretary Dong
Hong Ming Director
Guo Min Long Director
Li Hong Ming Executives
Jiang Ru Dong Securities Affairs Representative
Mao Wen Hua Executives
Sun Yang Director
Li Wei Jin Director
Luo Yu Hong Director
Pan Qing Hua Directors, executives
Chen Zheng Hua Supervisors
Jia Qiang Executives, directors